Blood vessel 'inflator' could be 'game-changer' for pancreatic cancer treatment
(Medical Xpress) -- Cancer Research UK scientists have shown that an enzyme can re-expand the insides of blood vessels allowing more drugs and large antibody molecules to reach pancreatic tumors, according to research published in GUT today.
The team at Cancer Research UKs Cambridge Research Institute showed that an enzyme called PEGPH20 stretched open the insides of blood vessels in mice. This allowed greater amounts of two different chemotherapy drugs - gemcitabine and doxorubicin - to reach tumours.
At the moment, it is difficult to deliver drugs to tumours because the blood vessels are tightly compressed. And there are large amounts of structural cement-like molecules surrounding the blood vessels in pancreatic tumors. This limits the transport of drugs to the tumor and prevents drugs from diffusing across the tumour to kill the cancer cells.
The main cement surrounding blood vessels consists of a bulky molecule called hyaluronan.
The scientists found that PEGPH20 removed hyaluronan and caused blood vessels to rapidly expand in pancreatic tumors, allowing free-flow of drugs to tumors.
They showed that combining PEGPH20 with chemotherapy drug gemcitabine blocked tumor growth and increased survival.
Study author, Professor David Tuveson, group leader at Cancer Research UKs Cambridge Research Institute, said: Adding this enzyme to treatments could be a game-changer for treatment of pancreatic cancer if clinical trials show it can be used to treat patients safely.
It made the shape of blood vessels wider and rounder essentially its the difference between changing the shape of blood vessels from a flat bicycle tyre to a pumped up one. This allowed drugs to easily travel to the tumor and destroy it, when previously this was incredibly difficult. Also, the expanded blood vessels now have holes that allow the drugs to reach the tumour more effectively.
Pancreatic cancer is the fifth most common cause of cancer death in the UK - around 8,000 people are diagnosed with the disease each year in the UK.
Survival from the disease is still low although the one-year survival rate for pancreatic cancer has more than doubled since the 1970s. Fewer than one in five patients survive their disease for more than a year after diagnosis.
Dr. Julie Sharp, Cancer Research UKs senior science information manager, said: Pancreatic cancer can be difficult to treat successfully because the disease is often diagnosed at a late stage, when it has already spread. This is why it is incredibly important to find ways to make treatments more effective.
Developing new ways to treat this disease, and other cancers where survivals still low, is a priority for the charity.
Cancer Research UK funded the largest ever trial for people with pancreatic cancer that can be operated on which changed the global treatment for the disease, helping to improve survival. But there is much more to be done.
Although its too early to say whether this enzyme can be used to treat patients with pancreatic cancer in the future, this research will help our understanding of the disease. The next stage is to test whether it is an effective and safe way to treat patients with the disease in clinical trials.
More information: Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut. Jacobetz et al.
Journal reference: Gut
Provided by Cancer Research UK
- Drug combination domino effect destroys pancreatic cancer cells Feb 22, 2012 | not rated yet | 0
- 'Detox protein' is collaborator in pancreatic and lung cancer development Jul 06, 2011 | not rated yet | 0
- Scientists discover how antibiotic molecule found in bacteria stops breast cancer Aug 22, 2011 | not rated yet | 0
- New drug substantially extends survival in pancreatic cancer Sep 16, 2008 | not rated yet | 0
- Scientists break through pancreas cancer treatment barrier Mar 19, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...
Cancer 4 hours ago | not rated yet | 0 |
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, ...
Cancer 6 hours ago | not rated yet | 0
New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...
Cancer 6 hours ago | 4.7 / 5 (7) | 1 |
(HealthDay)—For young adults needing either a chest or abdominopelvic computed tomography (CT), the short-term risk of death from underlying morbidity is greater than the long-term risk of radiation-induced ...
Cancer 7 hours ago | not rated yet | 0
In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.
Cancer 13 hours ago | not rated yet | 0 |
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
7 hours ago | 5 / 5 (2) | 0 |
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...
7 hours ago | 5 / 5 (2) | 2 |
Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...
4 hours ago | 3.6 / 5 (5) | 0 |
A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...
4 hours ago | not rated yet | 0 |
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
3 hours ago | 4.5 / 5 (10) | 1 |
University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...
4 hours ago | 5 / 5 (1) | 0 |